Where does Oculeve, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Oculeve, Inc. ranks #9,577 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Oculeve, Inc. hold?

Oculeve, Inc. holds 33 US utility patents granted between 2015 and 2021, spanning 12 technology areas.

What is Oculeve, Inc.'s Innovation Score?

Oculeve, Inc. has an Innovation Score of 34.5 out of 100 (48th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Oculeve, Inc. focus on?

Oculeve, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 27 patents, ranking #143 of 1,943 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Oculeve, Inc.'s patent grant rate increasing or decreasing?

Oculeve, Inc.'s recent grant velocity is -35% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Oculeve, Inc.'s patents?

Oculeve, Inc.'s patents average 16.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Oculeve, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Oculeve, Inc.

USPTO PatentsView assignee record - 33 granted patents across 12 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Oculeve ranks #9,577 of 49,997 tracked US assignees by granted-patent volume, with 33 patents across 12 technology areas.

#9,577
of 49,997 US assignees by volume: 48th percentile
by Innovation Score (34.5/100): 16.8
avg claims per patent: -35%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9577 · US Corporation #9,577 · 33 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 33 grants
UPPER-Q #9,577/49,997
PHOTO-FINISH NeoTract
CPC-FOCUS A61N · 12 areas
INNOV-THIN 34.5/100
CLAIMS-RICH 16.8 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -35% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: NeoTract, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Oculeve’s 34.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.2 pts (35%) Velocity 0.0 pts (0%) Breadth 12.2 pts (35%) Claim depth 10.1 pts (29%)

Qualcomm Incorporated · highest

85
Kompan A/S · near

34
Laboratorios DEL DR… · near

34
Oculeve · this assignee

34
Sequent Medical · near

34
TecPharma Licensing · near

34
3D Lighting… · lowest

7

What this shows Oculeve's Innovation Score is 34.5/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Oculeve?

Each dot is one of Oculeve’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Oculeve’s own 16.8 claims/patent is ABOVE the 15.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Oculeve vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Oculeve's grants concentrate

Oculeve, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 81.8% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2020 (9 grants) versus a trough of 1 in 2015. By volume, Oculeve sits between NeoTract, Inc. and Oath (Americas) Inc..

Neotract

33
Nomadix

33
North Carolina Ag…

33
Novozymes North A…

33
Osaka City Univer…

33
Oslo Universitets…

33
Otoy

33
Oath (Americas)

33
Oculeve ◀

33

What this shows Oculeve holds 33 patents at rank #9,575, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Oculeve

By rank, the assignees closest to #9,575 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Oculeve's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Oculeve, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Oculeve ranks #143 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Sequent Medical, Inc. 34 Kompan A/S 34 Laboratorios DEL DR. Esteve S.A. 34 TecPharma Licensing AG 34

Oculeve's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 48th percentile higher than 48% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Oculeve, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.0%
2016	2	6.1%
2017	7	21.2%
2018	4	12.1%
2019	6	18.2%
2020	9	27.3%
2021	4	12.1%

Which technologies does Oculeve, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 27

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 10

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 10

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 8

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 8

H01B - CABLES; CONDUCTORS; INSULATORS; Selection OF Materials FOR Their Conductive, Insulating OR Dielectric Properties 3

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 3

Y10T - Technical Subjects Covered BY Former US Classification 3

B29D - Producing Particular Articles From Plastics OR From Substances IN A Plastic State 2

A61B - DIAGNOSIS; SURGERY; Identification 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Oculeve, Inc.'s patent record in context - here's where to go next.

Oculeve, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 81.8% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #9,577 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Oculeve, Inc. against NeoTract, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.